QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
Free Trial

Oncology Institute (TOIIW) SEC Filings & 10K Form

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free TOIIW Stock Alerts
$0.23
0.00 (0.00%)
(As of 04/18/2024 ET)
Compare
Stock AnalysisChartCompetitorsFinancialsInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Recent Oncology Institute SEC Filings

Export to Excel
DateFilerForm TypeView
03/28/2024
5:47 AM		Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/30/2024
6:07 PM		Havencrest Healthcare Partners GP, LLC (Reporting)
Havencrest Healthcare Partners, L.P. (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
TOI HC I, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
6:19 PM		Havencrest Healthcare Partners GP, LLC (Reporting)
Havencrest Healthcare Partners, L.P. (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
TOI HC I, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
7:02 PM		Havencrest Healthcare Partners GP, LLC (Reporting)
Havencrest Healthcare Partners, L.P. (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
TOI HC I, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:00 PM		Havencrest Healthcare Partners GP, LLC (Reporting)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
4:01 PM		Havencrest Healthcare Partners GP, LLC (Reporting)
Havencrest Healthcare Partners, L.P. (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
TOI HC I, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:06 PM		Havencrest Healthcare Partners, L.P. (Filed by)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
Form SC 13D/A
12/28/2023
4:58 PM		BARASCH RICHARD A (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:46 PM		Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:38 PM		Johnson Karen Marie (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:27 PM		Kaushal Mohit (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:58 PM		O'Meara Maeve (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:06 PM		McGeorge Anne (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:16 PM		Ling Gabriel (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:09 PM		Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Pacala Mark L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
2:26 PM		Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Shah Mihir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
6:42 PM		Castle Jeremy (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
8:01 PM		Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
7:47 PM		Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Virnich Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
7:37 PM		Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Podnos Yale (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
6:27 PM		Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
4:27 PM		Hively Brad (Reporting)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/16/2023
3:40 PM		Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Podnos Yale (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
5:49 PM		Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
4:17 PM		Hively Brad (Reporting)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2023
7:00 AM		Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2023
1:36 PM		Castle Jeremy (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/30/2023
2:04 PM		Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
9:20 AM		FMR LLC (Filed by)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
Form SC 13G/A
06/15/2023
5:41 AM		Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2023
4:28 PM		Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Form DEFA14A
06/14/2023
4:22 PM		Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Form 8-K/A
06/12/2023
7:09 AM		Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2023
7:43 PM		Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Shah Mihir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
4:09 PM		Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
3:09 PM		Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2023
3:46 PM		Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Form DEF 14A
04/28/2023
3:51 PM		Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:TOIIW) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends